Cachet Pharmaceutical Co., Ltd.
Symbol: 002462.SZ
SHZ
12.28
CNYTrhová cena dnes
14.3690
Pomer P/E
0.7993
Pomer PEG
3.58B
MRK Cap
- 0.02%
Výnos DIV
Cachet Pharmaceutical Co., Ltd. (002462-SZ) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 10532.55 | 2885.6 | 2183.7 | 2338.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0.59 | 0.1 | 0.2 | 0.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 38852.37 | 9187.4 | 9948 | 8640.8 | |||||||||||||||||
balance-sheet.row.inventory | 10431.64 | 2561.7 | 2692.3 | 2185.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 630.57 | 156.7 | 171.6 | 120.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 60447.13 | 15630.5 | 14995.6 | 13285.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2752.52 | 679.7 | 735.9 | 850.3 | |||||||||||||||||
balance-sheet.row.goodwill | 1983.55 | 475.9 | 515.9 | 562.4 | |||||||||||||||||
balance-sheet.row.intangible-assets | 142.71 | 35.6 | 35.8 | 36.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2126.27 | 511.4 | 551.7 | 599 | |||||||||||||||||
balance-sheet.row.long-term-investments | 7.78 | 1.7 | 2.3 | 2.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 374.33 | 93 | 68.1 | 52.6 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 789.85 | 204.4 | 203 | 148.2 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 6050.75 | 1490.3 | 1561 | 1652.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.account-payables | 23067.09 | 5858.1 | 5319.5 | 4442.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 14121.28 | 3842.7 | 4068 | 3774.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 394.27 | 115.5 | 96.8 | 99.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
Deferred Revenue Non Current | -4.3 | -4.3 | 0 | 0 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 30.66 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 130.84 | 53 | 732.8 | 34 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 811.74 | 180.2 | 220 | 259.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
balance-sheet.row.total-liab | 42070.44 | 11029.3 | 10635 | 9281 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 1166.83 | 291.7 | 291.7 | 291.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 9684.4 | 2430.6 | 2268.1 | 2079.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3516.49 | 0 | 240 | 237.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2556.4 | 1518.2 | 1278.2 | 1278.2 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 16924.12 | 4240.5 | 4078 | 3886.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.minority-interest | 7503.32 | 1851 | 1843.6 | 1770 | |||||||||||||||||
balance-sheet.row.total-equity | 24427.44 | 6091.5 | 5921.6 | 5656.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66497.88 | - | - | - | |||||||||||||||||
Total Investments | 8.37 | 1.7 | 2.4 | 2.5 | |||||||||||||||||
balance-sheet.row.total-debt | 14902.36 | 4018.7 | 4276.8 | 4003.8 | |||||||||||||||||
balance-sheet.row.net-debt | 4370.4 | 1133.2 | 2093.2 | 1665.6 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 257.86 | 468.3 | 601.9 | 590.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 168.35 | 226.7 | 201.1 | 175.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 34.3 | 3.5 | -0.3 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -528.8 | -1216.3 | -133.8 | -47.7 | ||||||||||||||||
cash-flows.row.account-receivables | -601.58 | -2437.7 | -655.1 | -699 | ||||||||||||||||
cash-flows.row.inventory | 72.78 | -510.7 | -179.8 | 183.5 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 1766.3 | 704.7 | 467.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 1271.58 | 357.8 | 243.9 | 395.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1168.99 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.acquisitions-net | 50.76 | -1.6 | 59.2 | 1.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 3.92 | 0 | -16.2 | -42 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -25.33 | 10.9 | 2.3 | 1 | ||||||||||||||||
cash-flows.row.other-investing-activites | 31.44 | 3.8 | -55.5 | 4.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -168.68 | -175.4 | -257.1 | -293.5 | ||||||||||||||||
cash-flows.row.debt-repayment | -3431.74 | -4619.6 | -3975.2 | -4948.4 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -207.44 | -282.3 | -242.7 | -289.1 | ||||||||||||||||
cash-flows.row.other-financing-activites | 1938.41 | 4739.1 | 3884.8 | 4864 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -753.17 | -162.8 | -333.1 | -373.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.7 | -0.4 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 247.14 | -501.7 | 322.2 | 447.4 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 8914.64 | 1699.3 | 2201 | 1878.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 8667.5 | 2201 | 1878.8 | 1431.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 1168.99 | -163.4 | 913.1 | 1114.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.free-cash-flow | 971.3 | -352 | 666.2 | 856.9 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 30683.14 | 29996.2 | 26219.8 | 25625.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 28755.67 | 28018.5 | 24112.2 | 23484.9 | |||||||||||||||||
income-statement-row.row.gross-profit | 1927.46 | 1977.7 | 2107.6 | 2140.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 61.72 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1023.97 | 1072.1 | 1162 | 1103.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 29779.65 | 29090.6 | 25274.3 | 24588.6 | |||||||||||||||||
income-statement-row.row.interest-income | 189.45 | 31.1 | -22.4 | 17.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 281.99 | 202.1 | 226.7 | 408.3 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 904.8 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 573.55 | 556.4 | 936.9 | 830.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 583.96 | 555.3 | 644.9 | 824 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 187.67 | 178.7 | 176.6 | 222.1 | |||||||||||||||||
income-statement-row.row.net-income | 257.86 | 250.1 | 468.3 | 601.9 |
Často kladené otázky
Čo je Cachet Pharmaceutical Co., Ltd. (002462.SZ) celkové aktíva?
Cachet Pharmaceutical Co., Ltd. (002462.SZ) celkové aktíva sú 17120851592.000.
Aký je ročný obrat podniku?
Ročné príjmy sú 15651563096.000.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.063.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 3.329.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.008.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.019.
Aká je Cachet Pharmaceutical Co., Ltd. (002462.SZ) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 250060041.000.
Aký je celkový dlh firmy?
Celkový dlh je 4018688843.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 1072054997.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 2853572169.000.